172 related articles for article (PubMed ID: 21461046)
1. Expanding the Role of Neuromodulation for Overactive Bladder: New Indications and Alternatives to Delivery.
Le NB; Kim JH
Curr Bladder Dysfunct Rep; 2011 Mar; 6(1):25-30. PubMed ID: 21461046
[TBL] [Abstract][Full Text] [Related]
2. Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems.
Meng L; Tian Z; Zhang Y; Wang J; Liao L; Chen G; Tian X; Ma L; Li Y; Shi B; Zhang Y; Ling Q; Zhang P; Wei Z; Zhong T; Xu Z; Li J; Luo D
Sci Rep; 2022 Dec; 12(1):22299. PubMed ID: 36566332
[TBL] [Abstract][Full Text] [Related]
3. Evolving types of pudendal neuromodulation for lower urinary tract dysfunction.
Parodi S; Kendall HJ; Terrone C; Heesakkers JP
Cent European J Urol; 2024; 77(1):82-88. PubMed ID: 38645815
[TBL] [Abstract][Full Text] [Related]
4. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects.
Tilborghs S; De Wachter S
Expert Rev Med Devices; 2022 Feb; 19(2):161-187. PubMed ID: 35061951
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic value of neuromodulation in women].
van Ophoven A
Urologie; 2023 Feb; 62(2):153-164. PubMed ID: 36690725
[TBL] [Abstract][Full Text] [Related]
6. Neuromodulation in urology, state of the art.
Ammirati E; Giammò A; Manassero A; Carone R
Urologia; 2019 Nov; 86(4):177-182. PubMed ID: 31368415
[TBL] [Abstract][Full Text] [Related]
7. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
[TBL] [Abstract][Full Text] [Related]
8. Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation.
Martinson M; MacDiarmid S; Black E
J Urol; 2013 Jan; 189(1):210-6. PubMed ID: 23174264
[TBL] [Abstract][Full Text] [Related]
9. [Neuromodulation as a treatment for overactive bladder syndrome].
Smits MA; Marcelissen TA; van Kerrebroeck PE; de Wachter SG
Ned Tijdschr Geneeskd; 2012; 156(33):A4135. PubMed ID: 22894803
[TBL] [Abstract][Full Text] [Related]
10. New technologies in the management of overactive bladder: current research and future prospects.
Marinkovic SP
Ther Adv Urol; 2019; 11():1756287219844669. PubMed ID: 31040883
[TBL] [Abstract][Full Text] [Related]
11. Review of New Implantable Tibial Nerve Stimulators in Comparison to Established Third Line Treatment Modalities for Nonneurogenic Overactive Bladder.
Tipton WA; de Riese WTW; de Riese CS
Urol Pract; 2020 Nov; 7(6):530-537. PubMed ID: 37287172
[TBL] [Abstract][Full Text] [Related]
12. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
Hoda MR; Fornara P
Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
[TBL] [Abstract][Full Text] [Related]
13. Sacral neuromodulation for female pelvic floor disorders.
El-Azab AS; Siegel SW
Arab J Urol; 2019 Mar; 17(1):14-22. PubMed ID: 31258941
[No Abstract] [Full Text] [Related]
14. Introduction to sacral neuromodulation therapy for urinary bladder dysfunction using an InterStim system.
Harries F
Br J Nurs; 2020 May; 29(9):S23-S26. PubMed ID: 32407234
[TBL] [Abstract][Full Text] [Related]
15. Where Are We Headed with Neuromodulation for Overactive Bladder?
Jaqua K; Powell CR
Curr Urol Rep; 2017 Aug; 18(8):59. PubMed ID: 28656519
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of sacral neuromodulation system with new six-contact points electrode in pigs.
Wang Y; Liao L; Cong H; Zhao L; Chen G; Wang Z; Li X
Neurourol Urodyn; 2019 Apr; 38(4):1038-1043. PubMed ID: 30843257
[TBL] [Abstract][Full Text] [Related]
17. Refractory overactive bladder: Beyond oral anticholinergic therapy.
Glinski RW; Siegel S
Indian J Urol; 2007 Apr; 23(2):166-73. PubMed ID: 19675795
[TBL] [Abstract][Full Text] [Related]
18. Neuromodulation for overactive bladder.
Bartley J; Gilleran J; Peters K
Nat Rev Urol; 2013 Sep; 10(9):513-21. PubMed ID: 23817408
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different types of therapy for overactive bladder: A systematic review and network meta-analysis.
Liu P; Li Y; Shi B; Zhang Q; Guo H
Front Med (Lausanne); 2022; 9():1014291. PubMed ID: 36341256
[TBL] [Abstract][Full Text] [Related]
20. Real World Performance of Sacral Neuromodulation and OnabotulinumtoxinA for Overactive Bladder: Focus on Safety and Cost.
Chughtai B; Clemens JQ; Thomas D; Sun T; Ghomrawi H; Sedrakyan A
J Urol; 2020 Jan; 203(1):179-184. PubMed ID: 31347949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
